MLchartDataset catalogue

Namenda

Term · Oncology and biomedicine · MLC-T-ONC-005660

A drug used to treat dementia caused by Alzheimer disease. It is also being studied in the treatment of side effects from whole-brain radiation therapy for cancer and other conditions. Namenda blocks the uptake of calcium by certain brain cells and decreases their activity. It is a type of N-methyl-D-asparatate (NMDA) receptor antagonist. Also called memantine hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-005660
FieldOncology and biomedicine
Synonymsmemantine hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005660",
  "term": "Namenda",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat dementia caused by Alzheimer disease. It is also being studied in the treatment of side effects from whole-brain radiation therapy for cancer and other conditions. Namenda blocks the uptake of calcium by certain brain cells and decreases their activity. It is a type of N-methyl-D-asparatate (NMDA) receptor antagonist. Also called memantine hydrochloride.",
  "synonyms": [
    "memantine hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/namenda/"
}

Record 11,561 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.